Whilst weight loss was not imperative for clinically meaningful outcomes in MAFLD, the low-fat diet arm achieved ~ 4% weight loss and greater improvement in hepatic steatosis, visceral fat and insulin resistance (average of − 17%, − 76% and − 1.0 unit), respectively. Here, INS is linked to Hepatic steatosis.